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ABSTRACT
The interaction of the organic anion, fluorescein (FL), with mi­
tochondria in renal proximal tubule cells was investigated. Con- 
focal microscopy was used to demonstrate FL accumulation in 
mitochondria of intact cells. Phenylsuccinate inhibited the mi­
tochondrial accumulation of the FL analog, carboxyfluorescein 
(CF) indicating that the dicarboxylate carrier may be involved in 
the intracellular compartmentation of organic anions. To char­
acterize the interaction, radio-tracer uptake and respiration 
studies with renal mitochondria were carried out using succi­
nate as a substrate. Respiration measurements in freshly iso­
lated kidney cortex mitochondria revealed that FL inhibited
ADP-stimulated and uncoupled respiratory rate, indicating that 
the organic anion inhibited the availability of succinate as a 
reducing agent. A similar effect on mitochondrial respiration 
was found for PAH and phenylsuccinate. FL inhibited 14C- 
succinate uptake concentration-dependently, and Dixon anal­
ysis revealed that the nature of interaction between FL and 
succinate was competitive. values of 0.5 ± 0.2 and 1.1 ±0.8 
mM were calculated for respiration experiments and tracer 
uptake studies, respectively. The data demonstrate that FL 
competitively interacts with a mitochondrial dicarboxylate 
transporter.
Organic anions that are actively secreted by the kidney, 
accumulate within cells of the proximal tubule. Various in­
vestigations showed that the fluorescent organic anion, FL, is 
handled by proximal tubules in a way similar to p-aminohip- 
purate, the model substrate for the transport system. The 
advantage of using FL is that the compound can be visualized 
within cells and lumen using fluorescence microscopic tech­
niques (Sullivan et ah , 1990; Miller et ah, 1993; Masereeuw et 
ah , 1994). Confocal microscopic images showed that FL is 
sequestered in rat proximal tubule cells within vesicular 
compartments, the major one being mitochondria (Maser­
eeuw et ah, 1994).
Our study is concerned with the mechanism by which FL 
accumulates within mitochondria. So far, nine different an­
ion carriers have been found in the mitochondrial inner mem­
brane and all of these transporters play an important role in 
the regulation of cellular metabolism. The different carrier 
systems are closely related and • have common substrates 
(LaNoue and Schoolwerth, 1979; Pedersen, 1993). Other xe- 
nobiotics have been shown to interact with mitochondrial 
anion transport systems. For example, valproic acid noncom-
Received for publication F eb ru a ry  26, 1996.
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petitively inhibits succinate transport (Rumbach et ah} 1989). 
The immunosuppressive agent, cyclosporine A, showed two 
mechanisms of interaction: a noncompetitive interaction 
with succinate for binding to succinate-coenzyme Q dehydro­
genase, and competitive inhibition with an oxidized form of 
one of the enzyme components (Lemmi et al,, 1990). [Beta]- 
Lactam antibiotics have been reported to interact with the 
mitochondrial phosphate carrier. The carrier is acylated by 
these antibacterial agents, primarily resulting in irreversible 
injury to this carrier and secondarily to mitochondrial oxida­
tive metabolism (Tune, 1993). In each of these three exam­
ples, succinate-stimulated respiration is reduced either di­
rectly or indirectly. Measuring succinate stimulated oxygen 
consumption is a simple way to investigate drug effects on 
mitochondrial function. The rate of respiration is controlled 
by the uptake of the dicarboxylate into mitochondria. The 
principal transporter for uptake into mitochondria is the 
dicarboxylate carrier, although succinate may also be a sub­
strate for the related tri carboxyl ate and oxoglutarate carriers 
(LaNoue and Schoolwerth, 1979). The dicarboxylate carrier 
catalyzes electroneutral exchange of dicarboxyl ate s and 
phosphate through the mitochondrial inner membrane. Most 
of our present knowledge about mitochondrial succinate up­
take comes from studies with isolated rat liver mitochondria. 
The kinetics of succinate uptake appeared to be saturable,
ABBREVIATIONS: FL, fluorescein; CFDA, carboxyfluorescein-diacetate; CF, carboxyfluorescein; PAH, para-aminohippurate; PTC, proximal 
tubular cells; EGTA, ethylene glycol-bis-(j3-aminoethylether)-N, N,N',N'-etraacetic acid; BSA, bovine serum albumin.
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concentration-, temperature- and pH-dependent, and sensi­
tive to phenylsuccinate. Low concentrations of phenylsucci­
nate blocks dicarboxylate uptake in isolated mitochondria, 
but the drug is not transported into the matrix (Quagliariello 
et al., 1969; Palmieri et al., 1971).
We use confocal microscopy of intact renal proximal tubule 
cells, and radio-tracer uptake and respiration studies with 
renal mitochondria to demonstrate that substrates for the 
renal organic anion transport system competitively interact 
with the mitochondrial dicarboxylate carrier.
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Materials and Methods
M a te r ia ls . FL , succinic-acid, phenylsuccinic-acid and E G TA  were 
purchased from  Aldrich Chemie (Steinheim , Germ any) and [2,3- 
14C]succinic-acid (specific activity 2.2 GBq/mmol) from  D u Pont (Bos­
ton, M A). C FD A  and tetram ethylrosam ine were from  M olecular 
Probes (Eugene, OR). BSA and 4-(2-hy dr oxyethyl)-1-piper azine 
ethane sulfonic acid were obtained from Boehringer-M annheim  
(M annheim , Germ any). Sodium pentobarbital was acquired from  
Apharmo (Arnhem , The Netherlands) and heparin from  Organon 
(Oss, The Netherlands). A ll other chemicals were of analytical grade 
and purchased from  M erck (Darm stadt, G erm any) or Sigma (St. 
Louis, MO).
C o n fo cal im ages o f is o la te d  p ro x im a l tu b u la r  ce lls . Proxim al 
tubular cells were isolated as described in  detail previously (M aser­
eeuw et a l ,  1994). For microscopy, cells were transferred to a Teflon  
chamber w ith  a glass coverslip floor, containing 1.5 m l of incubation  
buffer (117.5 m M  N aC l, 4 m M  KC1, 1.2 m M  M g S 0 4, 0.95 m M  
K H 2P 0 4, 22.5 m M  NaHCOg, 11.1 m M  glucose and 2.5 m M  CaC l2). 
Cells were preincubated for 15 m in in presence or absence (controls) 
of phenylsuccinate (25 ¡iM or 1 m M ) or nocodazole (20 /¿M) a t 37°C  
under an atmosphere of 95% oxygen and 5% carbon dioxide. Subse­
quently, CFD A was added to the cells reaching a fin a l concentration 
of 2 ¡xM and incubation took place for 15 m in a t room tem perature. 
In  double labeling experiments, cells were preincubated for 15 m in a t 
37°C under an atmosphere of 95% oxygen and 5% carbon dioxide, 
then CFDA (2 /xM) and tetram ethylrosam ine (0.5 /xM) were added 
simultaneously. Incubation w ith  both dyes took place for 15 m in a t 
room tem perature. Confocal fluorescent images were obtained w ith  a 
Zeiss LSM  410 confocal microscope (C arl Zeiss, Oberkochen, G erm a­
ny). The system consisted of an inverted microscope, a m ixed argon/ 
krypton-ion laser w ith  the 488 and 568 lines as excitation source 
(intensity 15 m W ). The microscope was equipped w ith  a 40 X oil 
immersion objective, exhibiting a num erical aperture of 1.3. For 
measurement of tetram ethylrosam ine fluorescence, the 568-nm  la ­
ser line, a 575-nm  dichroic filte r and a 590-nm  long pass emission 
filte r were used. For measurements of CF, the 488-nm  laser line, a 
510-nm  dichroic filte r and 515-nm long pass emission filte r  were 
used. N eu tra l density filters passing 1 or 3% of the lig h t and 20%  
laser power were used to m inim ize photobleaching. The photom ulti­
p lier gain was adjusted so th at the average pixel in tensity in  the cells 
was between 40 and 60 on a scale of 0 to 255, and cellu lar autofluo­
rescence was undetectable. For dual labeling studies, the photom ul­
tip lie r gain in  the CF channel was adjusted so th a t the te tram eth ­
ylrosamine signal was not detectable. The software used to obtain  
the images was Zeiss LSM 4 (C arl Zeiss, Oberkochen, Germ any). 
Images were stored on an optical disk recorder and analyzed using a 
Macintosh computer equipped w ith  image analysis software (Im age  
1.54, N ational Institu tes of H ealth). The effect of phenylsuccinate on 
CF accumulation was measured. To this end, a field  containing 20 
cells was selected and a single 8-sec scan was collected in  confocal 
fluorescence mode. O f this image the average pixel in tensity for each 
cell was calculated of which the background was subtracted, and the  
value used was the mean of a ll measured cells. O f one preparation  
four fields were measured and averaged.
Is o la tio n  o f k id n e y  c o rte x  m ito c h o n d ria . R a t kidney cortex 
m itochondria were isolated as described by (C ain  and S k ille te r, 
1987), w ith  some modifications. A ll steps were carried out a t 4°C. 
B riefly , m ale W istar-H annover rats (230-280 g) were anesthetized
i.p. w ith  pentobarbital (60 mg/kg). H eparin  (125 U /100 g) was ad­
m inistered in  the fem oral vein. Mesenteric and celiac arteries were 
ligated and the aorta was cannulated above the renal arteries. The  
kidneys were perfused w ith  an ice-cold solution containing 140 m M  
N aC l and 10 m M  KC1, the vena cava in ferior was ligated  and the le ft 
renal vein was cut open. A fter perfusion the kidneys w ere removed 
and kept in  ice-cold isolation buffer (300 m M  m annito l, 10 m M  
4-(2-hydroxyetbyl)-l-p iperazine ethane sulfonic acid, 1 m M  E G T A , 1 
m g/m l BSA, adjusted to pH  7.4). The kidney capsule was removed, 
m edulla was dissected and the cortex was collected in  three tim es  
tissue w eight of isolation buffer. Tissue was homogenized in  six 
strokes by hand in  a Potter-E lvehjem  homogenizer w ith  Teflon pestle 
(Braun, Melsungen, Germ any). The clearance between pestle and 
Potter tube was 0.5 mm. The homogenate was filtered  through two  
layers of woven gauzes, and centrifuged for 10 m in a t 500 X g. 
Supernatant was collected and centrifuged for 7 m in a t 11,000 X g. 
Mitochondiûal pellet was washed w ith  isolation buffer and again  
centrifuged (7 m in, 11,000 X g). F in a l pellet was d ilu ted  to a con­
centration of 5 m g/m l m itochondrial protein in  respiration m edium  
(210 m M  m annitol, 10 m M  K C 1 ,10 m M  K H 2P 0 4, 0.5 m M  E G TA , 60 
m M  Tris-H C l, a t pH  7.4) and kept on ice.
Protein content was determ ined using the BioRad P rotein  Assay of 
BioRad (München, G erm any) w ith  BSA as the protein standard. The  
p urity  of the m itochondrial fraction was assessed by assaying the  
specific activ ity  of the following m arker enzymes, as described pre­
viously (Russel et a l , 1988): succinate dehydrogenase for m itochon­
dria, Na,K -A TPase for basolateral membranes, a lka lin e  phosphatase 
for brush-border membranes, acid phosphatase for lysosomes and 
NADPH-dependent cytochrome-c reductase according to O m ura and  
Takesue (1970) for smooth endoplasmic reticulum , The results o f the  
enzym atic analysis (means ±  S.D. of six d ifferent preparations, 
unless indicated otherwise) showed an enrichm ent in  succinate de­
hydrogenase of 3.4 ±  0.5-fold (n =  18), 1.3 ±  0.4-fold in  N a ,K - 
ATPase, 1.4 ±  0.5-fold in  alkaline phosphatase, 1.4 ±  0 .2-fold in  acid 
phosphatase and 0.9 ±  0.5-fold in  N A D PH -dependent cytochrome-c 
reductase. Respiration measurements or tracer uptake experim ents  
were carried out im m ediately after isolation of the m itochondrial 
fraction.
M ito c h o n d r ia l re s p ira tio n . Oxygen consumption was m ea­
sured using 1 mg of m itochondrial protein at 30°C w ith  a C lark-type  
platinum  electrode in  2.0 m l of respiration m edium , as previously  
described (C ain  and S kille ter, 1987). Succinate (10 m M ) was used as 
the metabolic substrate. The conversion of succinate is d irectly  
linked to the process of oxidative phosphorylation, and rotenone (5 
¡jM )  was added to block electron transport proxim al to succinate 
entry into the respiratory chain. A D P stim ulated respiration  (state  
3) was m easured in  the presence of 0.3 m M  A D P . D in itrophenol (44  
(jlM)  was used as an uncoupling agent. D initrophenol discharges the  
proton electrochemical gradient across the m itochondrial in n er 
m em brane, hereby stim ulating  oxygen consumption w ith o u t A TP  
synthesis. The composition of the solutions used for resp iration  ex­
perim ents is given in  the figure legends. Respiratory rates are ex­
pressed as nanogram  atoms of oxygen per m inute per m illig ram  of 
m itochondrial protein (ng atom O/min-mg prot.).
14C -S u c c in a te  u p ta k e . U ptake of 14C-succinate in to  m itochon­
dria  was measured in  trip licate  at 10°C. Incubation was started  by 
the addition of 25 jjlI of the m itochondrial suspension to 100 /xl 
respiration m edium  supplemented w ith  antim ycine (10 /¿M), ro te­
none (5 /iM ), the desired concentration of succinic acid and a tracer 
am ount of 14C-succinic acid (50 nC i). U ptake was stopped at appro­
priate  tim e in tervals by the addition of 2.5 m l ice-cold stop buffer 
(190 m M  m annitol, 10 m M  K C 1 ,10 m M  K H 2P 0 4, 0.5 m M  E G TA , 60 
m M  phenylsuccinic acid, a t p H  7.4). Separation of m itochondria and 
extram itochondrial m edium  took place through W hatm an G F /F  fil-
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ters, using a rapid vacuum filtration technique (Russel et ciL, 1988). 
Incubation tubes and filters were washed three times with 2.5 ml 
stop buffer. To the filters, 4 ml of scintillation fluid (Aqualuma Plus, 
Lumac, Schaersberg, The Netherlands) was added. The radioactivity
remaining: the filters was counted in LS 6000 LI
liquid scintillation counter. Corrections were made for nonspecific
filter binding in the absence of mitochondria. Uptake is expressed as 
pmol/mg mitochondrial protein.
Data analysis. All data are expressed as means ± S.D. and were 
performed on at least three different mitochondrial preparations.
Statistical differences between means determined using
way analysis of variance followed by the least significant difference
< .05.
The kinetic constants of the inhibitory potency of FL on succinate 
uptake in mitochondria were determined from the initial
uptakes (10 sec) at various substrate concentrations. Inhibition of FL 
on succinate uptake was expressed relative to the maximum inhibi­
tion achieved with phenylsuccinate, and calculated as:
y 0
y FL
a m  •  -11 i ^i I  r*  I < t ’
Vi V 100%PS
where V0 is
with fluorescein, VPL is the uptake of 100 jxM succinate determined
ps is the uptake of succi-
The log-concentration inhibition curves were analyzed by means of
calculation of K. for FL (Dixon,
assuming a one-site competition model. Transformation of the data 
according to Dixon showed the nature of inhibition, and allowed
. The K. value was determined
a standard deviation 
was derived from the sum of the estimated variance of each inter­
section point.
Results
Fig. 1.
after double-labeling with 0.5 /xM tetramethylrosamine (upper panel) 
and 2 /xM CFDA (lower panel). Images were collected as described in 
“Materials and Methods.” Tetramethylrosamine stains mitochondria
CFDA) indicates that this fluorescent anion is sequestered in the mito­
chondrial compartment. The polarity of the cells is based on the loca­
tion of the nucleus and mitochondria, which are basal in tubules. The 
experiment was replicated in four different isolations. Bar is 10 /xm.
Confocal m icroscopy, OFD*Ä is a nonfluorescent and M itochondria l re sp ira tio n . To determine the nature of
uncharged analog of FL that enters proximal tubular cells the interaction between FL and mitochondria, we measured
mainly by diffusion. Once inside, the compound is hydrolyzed respiration rates in isolated mitochondria. In figure 3, the 
to CF, an anion, which is highly fluorescent (Dive et a l control respiratory rate is shown as a function of succinate
1988). 1 shows confocal images of rat kidney PTC concentration. A clear concentration-dependent ADP-stimu-
incubated with 0.5 /xM tetramethylrosamine (upper panel) lated respiration (state 3) was observed, whereas the basal
and 2 ¡jM  CF (lower panel). Tetramethylrosamine stains respiration (state 2) and recovery respiratory rate after ADP
mitochondria (Whitaker et al., 1991) and it is obvious that CF consumption (state 4) were only slightly dependent on the
and tetram.ethylrosam.ine are localized in the same punctate succinate concentration. The concentration of succinate used
compartment. This is similar to what was found previously for most other experiments was 1.0 mM, which gives inaxi-
for FL (Masereeuw et al 1994) mum state three respiration rates. Cain and Skilleter (1987)
After isolation of rat PTC, there is still a clear distinction demonstrated that respiratory control ratio values (ratio of
between basolateral and brush-border region (fig. 2, upper state 3 over state 4 respiration) of more than 3 for succinate-
panel). The darker region in the image is the nucleus, which linked respiration are indicative of intact and well- coupled
is located at the basolateral side. The nuclear envelop should mitochondria. With 50 mM succinate, the respiratory control
be permeable to CF, and the relative fluorescence in this ratio value was 4.1 ± 0.2 (n = 4), indicating that our mito
region could be considered as an indication of the level of free 
drug in cytoplasm. In addition to accumulation of CF in 
mitochondria, some punctate fluorescence was observed at 
the brush-border side of the cell compared to the darker anions at 100 /xM on succinate stimulated respiration. No
nuclear region of the cells. When the cells were preincubated
chondrial preparation was of good quality and tightly cou-
pled.
Table 1 presents the effects of FL and various other organic
of these drugs could be observed on the
a l -with an inhibitor of mitochondrial dicarboxylate transport, 
phenylsuccinate, hardly any mitochondrial accumulation though there was a tendency for reduced basal respiration
could be observed for CF whereas accumulation at the brush- with FL and PAH. After addition of ADP (state 3) FL and
border side increased profoundly (fig. 2, lower panel). Phe- PAH significantly reduced respiratory rate, suggesting that
nylsuccinate inhibited CF accumulation by 65 
mined in four different preparations).
4% (deter the availability of succinate as a reducing agent was de-
. The other organic anions tested did not show any
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TABLE 1
Effect of various anionic drugs on succinate respiration in rat kidney cortex mitochondria
Drug6 N
Respiratory Rate (ng atom O/min ♦ mg Prot.)3
RCRrf
State 2a State 3a State 4" DNPC
Control 9 28 ± 7 97 ± 25 27 ± 6 77 ±  19 3.6 ±  0.2
Fluorescein 7 22 ± 6 67 ± 15* 25 ± 6 64 ±  31 2.8 ±  0.2®
p-Aminohippurate 3 17 ± 4 66 ± 8* 24 ± 4 54 ±  18 2,8 ± 0.2®
Probenecid 4 26 ± 10 104 ± 10 37 ± 8 93 ±  22 2.8 ± 0.4®
Phenylsuccinate 4 32 ± 6 86 ± 14 29 ± 4 63 ±  15 3.0 ±  0.3®
Valproate 4 24 ± 6 84 ± 26 31 ± 5 98 ±  6 2.7 ± 0.6e,f
Salicylate 4 27 ± 8 90 + 24 29 ± 10 83 ±31 3.2 ±  0.4
Indomethacin 4 32 ± 12 87 ±27 32 ± 11 70 ±  13 2.7 ±  0.6®
Naproxen 4 34 ± 10 89 ± 23 35 ± 9 86 ±  22 2.6 ±  0.4e/
a Oxygen consumption was measured before ADP addition (state 2), after addition of 0.3 mM ADR (state 3) and after ADR consumption (state 4). All data are 
expressed as means ±  S.D.
b Mitochondria were preincubated for 3 min in respiration buffer in presence of 100 /xM of the drug tested. 
c Uncoupled respiratory rate was measured in presence of 44 /¿M dinitrophenol (DNP).
*  Respiratory control ratio (RCR) is the ratio of state 3 over state 4 respiration,
0,f A one-way analysis of variance followed by the least significant differences test has been used to assess statistical differences between means. ° P <  .05 vs. 
control; 'P  <  .05 vs. salicylate.
known. Phenylsuccinate inhibited CF entry into mitochon­
dria, but had no effect on cellular uptake of the CF precursor, 
CFDA, because CFDA enters cells by simple diffusion and is 
than hydrolyzed to the fluorescent anion CF.
Phenylsuccinate blocks mitochondrial dicarboxylate up­
take irreversibly (Quagliariello et al., 1969; Palmieri et al., 
1971). It also blocks CF uptake by mitochondria in intact 
PTC, suggesting that CF probably enters mitochondria via 
the dicarboxylate transporter. However, phenylsuccinate 
seemed to prevent cellular exit of the fluorescent compound 
as well. As was reported previously, the passive permeability 
of the brush-border membrane for organic anions is consid­
erably greater than the permeability of the basolateral mem­
brane, and efflux across the brush-border membrane is there­
fore the principal route of exit (Pritchard and Miller, 1992). 
Although efflux is energetically downhill and need not be 
mediated, potential-driven efflux and anion exchange have 
been reported for organic anions at the brush-border mem­
brane (Russel et al., 1988; Pritchard and Miller, 1992). In 
addition, Schmitt and Burckhardt (1993) recently found an 
exchange mechanism for p-aminohippurate with dicarboxy- 
lates in bovine brush-border membranes. Although the exis­
tence of this exchange mechanism has, as yet, not been 
shown in rat brush-border membrane, phenylsuccinate 
might be able to block CF-anion exchange and, as a conse­
quence, CF would be trapped within the proximal tubular 
cells.
To characterize the interaction between FL and mitochon­
dria, studies were performed with freshly isolated kidney 
cortex mitochondria, using succinate as substrate. The oxy­
gen uptake results demonstrate that our mitochondrial frac­
tion was of good quality, with oxidation and phosphorylation 
tightly coupled. The effect of FL and various anionic drugs 
were tested on succinate stimulated respiration. Indometha- 
cin, naproxen, valproic acid and probenecid tended to in­
crease state 4 respiration. This can be explained as uncou­
pling of mitochondrial oxidation and phosphorylation, which 
is in good agreement with earlier findings for these drugs 
(Pakarinen, 1970; McDougall et a l , 1983; Ponchaut and 
Veitch, 1993). FL, PAH and phenylsuccinate reduced the 
availability of succinate for oxidation. Dixon analysis re­
vealed that the type of interaction between FL and succinate 
was competitive. This inhibitory effect may either be a result
Respiratory rate (ng atom O/min mg prot.)
140-
120-
100
80-
60
40-
20-
0
2.5 mM succinate A—■ state 2
• — state 3
A - state 4
0 100 200 300
1 2 0 -
10 mM succinate
40-
20~
0
0 100 200 300 400 500
Fluorescein (\itA)
Fig. 4. Upper panel: Respiration of rat kidney cortex mitochondria with 
2.5 mM succinate as substrate, after preincubation of mitochondria for 
3 min with different concentrations of FL. Respiration was measured in 
2 ml buffer at 30°C, in basal state (state 2), in the ADP-stimulated state 
(state 3) and after ADP consumption (state 4). Data points are ex­
pressed as means ± S.D. of three different isolations. Lower panel: 
Similar conditions as above but 10 mM succinate was used as sub­
strate. DNP: respiratory rate measured after the addition of 44 ¡jlM 
dinitrophenol. Data points are means ± S.D. of four different isolations. 
*P <  .05 vs. control respiration (0 jxM FL).
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1/Respiratory rate (ng atom 0/min*mg prot.) % Succinate control uptake
0.030 -
0 .0 2 5 -
0 .020 “
0.015“
0.010-
0 .005“
0.000
1250
Fluorescein concentration (pM)
Fig. 5. Dixon-plot of the reciprocal respiratory rate of rat kidney cortex 
mitochondria, measured after ADP addition (state 3), as a function of FL 
concentration. Two different substrate concentrations were used (2.5 
and 10 mM succinate). Data points are expressed as means of three or 
four different isolations. The regression equations for both lines are 
1.3‘1CT5’ X + 1.4-1CT2 (R2 -  0.85) and 5.5-10~6-x + 1.0*10~2 (R2 -  
0.57), for 2.5 mM and 10 mM succinate, respectively,
Succinate uptake (pmol/mg prot.)
1500
1200  -
control
o— + phenylsuc.
900 -
600 -
300 -
0 5 10 15
Minutes
20 25 30
Fig. 6. Time-dependent uptake of 14C-succinate into freshly isolated 
rat kidney cortex mitochondria at 10°C, with and without preincubation 
with 12.5 mM phenylsuccinate for 60 min. The extramitochondrial 
concentration was 500 ju,M succinate. Phenylsuccinate is the ultimate 
inhibitor of dicarboxylate-mediated transport in mitochondria and 
therefore used to determine the contribution of diffusion in transmito- 
chondrial transport of succinate. Values are expressed as means ± 
S.D. of four different isolations.
of competition for transport across the mitochondrial inner 
membrane, or competition for binding at the enzyme complex 
succinate-coenzyme Q dehydrogenase.
To distinguish between these effects, uptake of 14C-labeled 
succinate was measured in mitochondria with metabolism 
blocked by rote none and antimycine. FL inhibited succinate 
uptake competitively. The inhibitory constant calculated 
from the tracer uptake experiments (1.1 mM) was two times 
higher than the constant obtained from the respiration stud­
ies (0.5 mM), although the difference was not significant. An 
explanation may be the difference in experimental condi­
tions. However, it should be noticed that the rather low 
correlation coefficient of the regression line from 10 mM 
succinate data points in figure 5 obviously weakens the reli-
Fluorescein  concentration  (pM)
Fig. 7. inhibition of 14C-succinate uptake into freshly isolated rat kid­
ney cortex mitochondria at 10°C at various concentrations of FL. The 
extramitochondrial succinate concentration was 100 /xM. Inhibition was 
expressed relative to the maximum inhibition achieved with phenylsuc­
cinate (12.5 mM). Uptake was measured at 10 sec, and values are 
expressed as means ± S.D. of four different isolations.
1/uptake  (nmol/mg p r o t / m i n )
•  100 jjM sue.
250 pM sue. 
500 |jM sue.
1500 3000 4500 6000
F lu o resc ein  ( hM)
Fig. 8. Dixon-plot of the reciprocal uptake of 14C-succinate into freshly 
isolated rat kidney cortex mitochondria, as a function of FL concentra­
tion. The extramitochondrial concentrations were 100, 250 and 500 i±M 
of succinate. Uptake was measured at 10 sec, and values are ex­
pressed as means of four different isolations. The regression equations 
for the lines are 7.6-10'4- x  + 1.01 (R2=.95), 4.7-10"4- X -I- 0.60 (R* = 
0.97) and 1.5'10“ 4-x+0.36 (R2 = 0.93), for 100, 250 and 500 /xM 
succinate, respectively.
ability of the estimated inihibitory constant of FL with re­
spect to mitochondrial respiration.
Inhibition of succinate uptake by FL together with the 
confocal observations for CF indicate that FL may be a sub­
strate for the mitochondrial dicarboxylate carrier. Moreover, 
the comparable effect of PAH on mitochondrial respiration 
suggests that mitochondrial uptake may also be involved in 
the intracellular compartmentation of this organic anion. 
However, only direct measurement of (radiolabeled) FL and 
PAH uptake will give the decisive answers. It has been 
shown previously that metabolic substrates affected organic 
anion uptake in renal proximal tubules. Cis-inhibition with 1 
mM glutarate, adipate or a-ketoglutarate reduced tubular 
uptake of 10 juM FL, whereas preincubation with 100 (jM of 
these dicarboxylates stimulated cellular uptake (Sullivan 
and Grantham, 1992). Nikiforov and Ostretsova (1992) sug­
gested that cellular FL uptake was linked to gluconeogenesis; 
however, the relationship between cellular uptake and oxi­
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dative metabolism remained unexplained. The metabolic 
substrate, pyruvate (5 mM), stimulated oxygen consumption 
and tissue accumulation of 50 jjM  FL in kidney cortex slices. 
Regarding the results of our investigation, it may be specu­
lated that this increase in tissue FL accumulation was due to 
an enhanced mitochondrial uptake of this organic anion. 
Exogenous administered pyruvate is rapidly taken up by the 
cells and sequestered within mitochondria, where it will be 
carboxylated to malate via the gluconeogenic pathway. Sub­
sequently, malate is transported to cytoplasm via the dicar­
boxylate carrier, which may occur in exchange for FL, This 
could explain the enhanced gluconeogenic rate found in the 
cortex slices exposed to pyruvate and FL.
It seems unlikely that the interaction between FL and 
succinate will have clinically significant implications. When 
FL is used as a diagnostic agent, concentrations reached in 
plasma will be less than 1 juM. From a previous study we can 
estimate that the final concentration in renal PTC will never 
exceed 5 juM, because at low extracellular concentrations the 
compound accumulates in renal cells reaching a 3- to 5-fold 
concentration intracellulary (Masereeuw et a l , 1994). Our 
results demonstrate that effective inhibition was not found 
for concentrations below 100 ¡jlM .
In conclusion, the interaction between the organic anion 
FL and mitochondria seems to be specific. Confocal images 
showed that the FL analog CF accumulates in mitochondria 
of rat PTC. Mitochondrial accumulation of CF was inhibited 
by the dicarboxylate uptake blocker, phenylsuccinate. Respi­
ration and radio-tracer uptake studies showed that FL com­
petitively interacts with the mitochondrial dicarboxylate car­
rier.
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